03/06/2024 Information Disclosure on Share Issuance for 2023 Dividend Payment and Selection of the Record Date
31/05/2024 Official Letter No. 3325/UBCK-QLCB dated May 28, 2024 regarding the Reporting Documents on Share Issuance for Dividend Payment of DBD
21/05/2024 Information Disclosure on the Change of the Company Secretary cum Corporate Governance Officer
07/05/2024 Resolution of the Board of Directors on the Implementation of the Share Issuance Plan for 2023 Dividend Payment
02/05/2024 Information Disclosure on the Resolution of the Board of Directors regarding the Election of the Chairman of the Board, the Dismissal and Election of the Audit Committee
20/04/2024 Resolution of the Board of Directors on the Re-appointment of the General Director and Deputy General Director
17/04/2024 Resolution of the Board of Directors on the Approval of the List of Candidates for the Board of Directors for the 2024–2029 Term
26/03/2024 Explanation for the Variance of 10% or More in Net Profit After Tax on the Consolidated and Separate Financial Statements Compared to the Same Period in 2022
13/01/2024 Appellate Judgment of the Ho Chi Minh City People’s Court regarding the dispute over a goods sale and purchase contract between DBD and Dong Nam
30/10/2023 Explanation for the Variance of 10% or More in Net Profit After Tax on the Consolidated and Separate Financial Statements Compared to the Same Period in 2022
21/08/2023 Report on Change in Ownership of Major Shareholders and Investors Holding 5% or More of Closed-End Fund Certificates
04/08/2023 List of Related Persons of the Company in the Semi-Annual Corporate Governance Report 2023, No. 858/BC-DBD dated July 29, 2023
25/07/2023 Explanation for the Variance of 10% or More in Net Profit After Tax on the Consolidated and Separate Financial Statements for the Second Quarter of 2023 Compared to the Same Period in 2022
17/07/2023 Resolution of the Board of Directors No. 814/NQ-HĐQT dated July 17, 2023 on the Selection of the Auditing Firm for 2023
30/06/2023 Resolution of the Board of Directors No. 736/NQ-DBD-HĐQT dated June 30, 2023 on the Implementation of the Investment in a Small-Volume Parenteral Drug Manufacturing Plant
